Koch Thomas Von - Net Worth and Insider Trading
Koch Thomas Von Net Worth
The estimated net worth of Koch Thomas Von is at least $23 Million dollars as of 2024-11-08. Koch Thomas Von is the 10% Owner of DiaMedica Therapeutics Inc and owns about 5,526,435 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $23 Million. Details can be seen in Koch Thomas Von's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Koch Thomas Von has not made any transactions after 2024-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Koch Thomas Von
Koch Thomas Von Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Koch Thomas Von owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Koch Thomas Von’s form 4 insider trades.
Insider Ownership Summary of Koch Thomas Von
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2024-06-28 | 10 percent owner |
Koch Thomas Von Latest Holdings Summary
Koch Thomas Von currently owns a total of 1 stock. Koch Thomas Von owns 5,526,435 shares of DiaMedica Therapeutics Inc (DMAC) as of June 28, 2024, with a value of $23 Million.
Latest Holdings of Koch Thomas Von
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2024-06-28 | 5,526,435 | 4.18 | 23,072,866 |
Holding Weightings of Koch Thomas Von
Koch Thomas Von Form 4 Trading Tracker
According to the SEC Form 4 filings, Koch Thomas Von has made a total of 5 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 1,200,000 shares on June 28, 2024, which cost Koch Thomas Von around $3 Million.
Insider Trading History of Koch Thomas Von
- 1
Koch Thomas Von Trading Performance
GuruFocus tracks the stock performance after each of Koch Thomas Von's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Koch Thomas Von is 6.54%. GuruFocus also compares Koch Thomas Von's trading performance to market benchmark return within the same time period. The performance of stocks bought by Koch Thomas Von within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Koch Thomas Von's insider trading performs compared to the benchmark.
Performance of Koch Thomas Von
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.74 | | | | | |
| Relative Return to S&P 500(%) | 10.55 | | | | | |
Koch Thomas Von Ownership Network
Ownership Network List of Koch Thomas Von
Ownership Network Relation of Koch Thomas Von
Koch Thomas Von Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Koch Thomas Von is the 10 percent owner of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Jan Stahlberg , CFO and Secretary Scott Kellen , and director & President and CEO Dietrich John Pauls .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Koch Thomas Von made 2 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 2,670,588. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 58,364 shares made by David J. Wambeke , a net purchase of 1,200,000 shares made by Jan Stahlberg , and a net purchase of 65,000 shares made by Randall Michael Giuffre .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,067,889 shares were bought by its insiders, resulting in a net purchase of 4,067,889 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Koch Thomas Von Mailing Address
Above is the net worth, insider trading, and ownership report for Koch Thomas Von. You might contact Koch Thomas Von via mailing address: Tomenterprise Ab, Box 5322, Stockholm V7 102 47.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
